SAN DIEGO — Use of an AI-supported software to interpret spirometry curves resulted in more accurate diagnoses made by general practitioners, according to research presented at the American Thoracic Society International Conference.“General practitioners often don’t feel comfortable to execute and interpret spirometry due to a lack of training and expertise,” Elena Smets,
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab. Chronic obstructive pulmonary disease patients with typ.
Phase 3 Trial: Dupilumab Reduces Type 2 Inflammation in COPD Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO — The absolute change in FVC at 48 weeks was similar between patients with idiopathic pulmonary fibrosis receiving pamrevlumab vs. placebo, according to a presentation at the American Thoracic Society International Conference.Pamrevlumab (FibroGen) is a fully human monoclonal antibody that impedes connective tissue growth factor, according to researchers.
SAN DIEGO — A third of patients with obstructive sleep apnea had an apnea-hypopnea index less than 10 events per hour after oral appliance therapy, according to research presented at the American Thoracic Society International Conference.Further, for those who still had OSA after 4-week oral appliance therapy, adding on another therapy other than CPAP resolved OSA for most patients,